EichorEICHOR
Location: Huntersville Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Huntersville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Phase 3 · Stern Research Partners, LLC · Harmony Biosciences Management, Inc. · NCT07500090
Study of XB010 in Subjects With Solid Tumors
Phase 1 · Carolina BioOncology Institute · Exelixis · NCT06545331
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Novant Health Cancer Institute - Huntersville · NRG Oncology · NCT05624996
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Onsite Clinical Solutions - Huntersville · Eli Lilly and Company · NCT06857942
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Phase 1 · Carolina BioOncology Institute · Peel Therapeutics Inc · NCT05329103
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Novant Health Cancer Institute - Huntersville · Alliance for Clinical Trials in Oncology · NCT07091617
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Phase 1 · Carolina BioOncology · FBD Biologics Limited · NCT05892718
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · Rosedale Health and Wellness · Gilead Sciences · NCT07645287
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced S
Phase 1/Phase 2 · Carolina BioOncology Institute · ModernaTX, Inc. · NCT05533697
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Phase 1/Phase 2 · Carolina BioOncology Institute · Terremoto Biosciences Inc. · NCT07109726
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Novant Health Cancer Institute - Huntersville · Alliance for Clinical Trials in Oncology · NCT06876714
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Piedmont Plastic Surgery and Dermatology- Site Number : 8400 · Sanofi · NCT07290803
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Phase 1 · Carolina BioOncology Institute · Conjupro Biotherapeutics, Inc. · NCT07317505
E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Levine Cancer Institute - Huntersville · NRG Oncology · NCT06748222
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Phase 1 · Carolina BioOncology Institute /ID# 225704 · Calico Life Sciences LLC · NCT04777994
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Phase 1/Phase 2 · Carolina BioOncology Institute · Corbus Pharmaceuticals Inc. · NCT06265727
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central
Phase 2/Phase 3 · Huntersville, North Carolina · Centessa Pharmaceuticals (UK) Limited · NCT07598708
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Advanced Respiratory and Sleep Medicine · Uniquity One (UNI) · NCT06496620
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Therapeutics, Inc · NCT06528314
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Phase 1 · Carolina BioOncology Institute, LLC · BioNTech SE · NCT06750185
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio, Inc. · NCT06419374
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Phase 3 · Ardelyx · NCT07382167
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Novant Health Cancer Institute - Huntersville · NRG Oncology · NCT04852887
A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSm
NA · J Chichetti PLLC 2 · Dentsply Sirona Implants and Consumables · NCT07290790
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated
Phase 2 · Altimmune, Inc. · NCT07009860
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · Pfizer · NCT06989437
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06568367
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · Sanofi · NCT06241118
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2 · Huntersville, North Carolina · Centessa Pharmaceuticals (UK) Limited · NCT06752668
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Phase 3 · Regeneron Pharmaceuticals · NCT06585410
Look up another city
Look up another condition